NASDAQ · Medical - Healthcare Information Services

ACON (ACON) Stock

$2.36 -0.84% NASDAQ: ACON Healthcare

Valuation

MetricValue
Price$2.36
Market Cap$1.26M
P/E Ratio-0.24
P/B Ratio0.21
P/S Ratio22.05
EPS (TTM)$-13.61
52-Week High$12.03
52-Week Low$2.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1.05%
ROA-55.81%
ROCE0.00%
Gross Margin—
Operating Margin—
Net Margin-103.36%
Debt/Equity0.00
Current Ratio14.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-6.0M$-5.0M$-6.0M$-7.0M
Net Profit$-5.0M$-7.0M$-5.0M$-7.0M$-7.0M
EPS$-120035.00$-177396.00$-79782.00$-7480.21$-13.61
Op Margin-4897.9%-9201.2%-6466.5%-12057.2%-9312.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$3.0M$2.0M$2.0M$13.67T
Total Liabilities$8.0M$1.0M$3.0M$1.0M$837.3B
Cash$0$1.0M$1.0M$0$12.02T
Borrowings$2.0M$0$1.0M$0$0

Latest News

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice GlobeNewswire · Jul 21, 2026 Aclarion Announces Texas Spine Care Center as New CLARITY Site GlobeNewswire · Jul 7, 2026 Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub GlobeNewswire · Jun 10, 2026 Aclarion Launches Market Access Program With PRIA Healthcare MT Newswires · Jun 9, 2026 Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-5.0M$-4.0M$-5.0M$-7.16T
Investing Cash Flow$0$0$0$-1.0M$-203.9B
Financing Cash Flow$0$0$0$-1.0M$18.95T
Net Cash Flow$0$1.0M$0$-1.0M$11.58T
Free Cash Flow$-2.0M$-5.0M$-4.0M$-6.0M$-7.16T

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-407075548.89%
Quick Ratio14.81
Interest Coverage—
Return 1Y-63.74%
Return 3Y-100.00%
Return 5Y—

Ownership

Insiders Held26.20%
Institutions Held4.35%
Institutions Float Held5.90%
Institutional HolderSharesReport Date
Osaic Holdings Inc.34,9452026-03-31
Geode Capital Management, LLC31,2152026-03-31
CAPTRUST Financial Advisors14,5592026-03-31
Bank of Montreal /CAN/10,0002026-03-31
UBS Group AG9,6472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ACON

ACON is led by CEO Brent Ness, employs 5 people, headquartered in US, publicly traded since 2022.

ACON stock trades at $2.36 with a market capitalization of $1.26M. The stock is valued at a price-to-earnings (P/E) ratio of -0.24, price-to-book of 0.21, price-to-sales of 22.05. Over the past 52 weeks the stock has ranged between $2.06 and $12.03, and currently trades 80.4% below its 52-week high.

On profitability, ACON generates a return on equity (ROE) of -1.05%, return on capital employed of 0.00%, a net profit margin of -103.36%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides